Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 16 studies | 21% ± 8% | |
plasmacytoid dendritic cell | 9 studies | 25% ± 6% | |
mast cell | 8 studies | 21% ± 7% | |
oligodendrocyte | 8 studies | 28% ± 9% | |
epithelial cell | 6 studies | 27% ± 10% | |
squamous epithelial cell | 4 studies | 32% ± 7% | |
endothelial cell | 4 studies | 24% ± 8% | |
connective tissue cell | 4 studies | 25% ± 6% | |
myofibroblast cell | 4 studies | 23% ± 7% | |
retinal pigment epithelial cell | 4 studies | 44% ± 19% | |
melanocyte | 4 studies | 55% ± 17% | |
astrocyte | 4 studies | 21% ± 3% | |
placental villous trophoblast | 3 studies | 28% ± 7% | |
GABAergic neuron | 3 studies | 25% ± 8% | |
glutamatergic neuron | 3 studies | 34% ± 18% | |
granulocyte monocyte progenitor cell | 3 studies | 24% ± 4% | |
type I pneumocyte | 3 studies | 19% ± 4% | |
goblet cell | 3 studies | 36% ± 15% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 32% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1949.89 | 244 / 245 | 98% | 17.25 | 494 / 502 |
skin | 97% | 1391.90 | 1759 / 1809 | 100% | 129.27 | 472 / 472 |
breast | 99% | 1618.12 | 456 / 459 | 97% | 23.45 | 1085 / 1118 |
adrenal gland | 100% | 8687.50 | 258 / 258 | 96% | 30.43 | 220 / 230 |
bladder | 100% | 4023.05 | 21 / 21 | 92% | 43.58 | 464 / 504 |
brain | 95% | 1324.38 | 2504 / 2642 | 97% | 15.96 | 684 / 705 |
lung | 100% | 3061.45 | 577 / 578 | 91% | 17.64 | 1051 / 1155 |
uterus | 99% | 1481.99 | 169 / 170 | 85% | 19.90 | 391 / 459 |
kidney | 100% | 2117.37 | 89 / 89 | 83% | 21.20 | 745 / 901 |
ovary | 100% | 8610.42 | 180 / 180 | 81% | 11.60 | 350 / 430 |
esophagus | 100% | 3131.72 | 1445 / 1445 | 75% | 13.32 | 137 / 183 |
liver | 97% | 1210.49 | 220 / 226 | 73% | 10.45 | 298 / 406 |
intestine | 96% | 2791.47 | 925 / 966 | 74% | 22.11 | 392 / 527 |
thymus | 98% | 1253.17 | 640 / 653 | 55% | 5.92 | 332 / 605 |
pancreas | 42% | 496.69 | 139 / 328 | 94% | 23.54 | 167 / 178 |
stomach | 64% | 777.92 | 230 / 359 | 64% | 12.76 | 182 / 286 |
eye | 0% | 0 | 0 / 0 | 100% | 271.17 | 80 / 80 |
spleen | 100% | 3417.94 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 123.91 | 1 / 1 |
adipose | 100% | 1680.95 | 1199 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1801.71 | 1328 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 2944.70 | 850 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 88% | 3844.25 | 817 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 64% | 7.78 | 29 / 45 |
lymph node | 0% | 0 | 0 / 0 | 38% | 2.92 | 11 / 29 |
muscle | 9% | 63.62 | 74 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016266 | Biological process | O-glycan processing |
GO_0009312 | Biological process | oligosaccharide biosynthetic process |
GO_0009247 | Biological process | glycolipid biosynthetic process |
GO_0009101 | Biological process | glycoprotein biosynthetic process |
GO_0018146 | Biological process | keratan sulfate biosynthetic process |
GO_0097503 | Biological process | sialylation |
GO_1903238 | Biological process | positive regulation of leukocyte tethering or rolling |
GO_1990743 | Biological process | protein sialylation |
GO_0019082 | Biological process | viral protein processing |
GO_0030194 | Biological process | positive regulation of blood coagulation |
GO_0050890 | Biological process | cognition |
GO_0030259 | Biological process | lipid glycosylation |
GO_0006486 | Biological process | protein glycosylation |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0000139 | Cellular component | Golgi membrane |
GO_0032580 | Cellular component | Golgi cisterna membrane |
GO_0008373 | Molecular function | sialyltransferase activity |
GO_0047288 | Molecular function | beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminide alpha-2,3- sialyltransferase |
GO_0008118 | Molecular function | N-acetyllactosaminide alpha-2,3-sialyltransferase activity |
GO_0003836 | Molecular function | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity |
Gene name | ST3GAL4 |
Protein name | SIAT4C protein (ST3 beta-galactoside alpha-2,3-sialyltransferase 4, isoform CRA_c) (cDNA, FLJ95600, Homo sapiens sialyltransferase 4C (beta-galactosidealpha-2,3-sialyltransferase) (SIAT4C), mRNA) ST3 beta-galactoside alpha-2,3-sialyltransferase 4 CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4 (Alpha 2,3-ST 4) (Beta-galactoside alpha-2,3-sialyltransferase 4) (EC 2.4.3.2) (EC 2.4.3.4) (Alpha 2,3-sialyltransferase IV) (Gal-NAc6S) (Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase) (Gal-beta-1,4-GlcNAc-alpha-2,3-sialyltransferase) (N-acetyllactosaminide alpha-2,3-sialyltransferase) (EC 2.4.3.6) (SAT-3) (ST-4) (ST3Gal IV) (ST3GalIV) (ST3GalA.2) (STZ) (Sialyltransferase 4C) (SIAT4-C) |
Synonyms | STZ SIAT4C hCG_37591 NANTA3 CGS23 |
Description | FUNCTION: A beta-galactoside alpha2-3 sialyltransferase involved in terminal sialylation of glycoproteins and glycolipids . Catalyzes the transfer of sialic acid (N-acetyl-neuraminic acid; Neu5Ac) from the nucleotide sugar donor CMP-Neu5Ac onto acceptor Galbeta-(1->3)-GalNAc- and Galbeta-(1->4)-GlcNAc-terminated glycoconjugates through an alpha2-3 linkage . Plays a major role in hemostasis. Responsible for sialylation of plasma VWF/von Willebrand factor, preventing its recognition by asialoglycoprotein receptors (ASGPR) and subsequent clearance. Regulates ASGPR-mediated clearance of platelets (By similarity). Participates in the biosynthesis of the sialyl Lewis X epitopes, both on O- and N-glycans, which are recognized by SELE/E-selectin, SELP/P-selectin and SELL/L-selectin. Essential for selectin-mediated rolling and adhesion of leukocytes during extravasation . Contributes to adhesion and transendothelial migration of neutrophils likely through terminal sialylation of CXCR2 (By similarity). In glycosphingolipid biosynthesis, sialylates GM1 and GA1 gangliosides to form GD1a and GM1b, respectively . Metabolizes brain c-series ganglioside GT1c forming GQ1c (By similarity). Synthesizes ganglioside LM1 (IV3Neu5Ac-nLc4Cer), a major structural component of peripheral nerve myelin . . |
Accessions | ENST00000528858.5 ENST00000676867.1 Q6IBE6 ENST00000449406.6 [Q11206-3] E9PMC7 A0A7I2V4F4 A0A7I2V5F3 ENST00000534452.5 ENST00000356132.9 E9PPJ6 E9PKJ2 ENST00000677503.1 ENST00000526311.5 ENST00000678865.1 ENST00000531217.5 E9PNJ9 ENST00000227495.10 [Q11206-5] A0A7I2V2H5 ENST00000532243.5 [Q11206-2] ENST00000534457.5 [Q11206-6] A0A7P0RGI5 ENST00000530591.5 [Q11206-5] ENST00000526727.5 [Q11206-1] A0A7I2V4R4 ENST00000392669.6 [Q11206-1] ENST00000676545.1 ENST00000677721.1 A0A7I2V4V4 ENST00000444328.7 [Q11206-1] ENST00000534083.5 [Q11206-1] ENST00000534733.6 ENST00000524860.1 E9PN64 Q11206 E9PQZ2 |